MAP Patient Access

MAP Patient Access specializes in helping biopharma and medtech companies achieve faster and more successful patient access to innovative medicines and technologies. They have supported over 200 Health Technology Assessment submissions with a reported 95% positive outcome rate for clients seeking reimbursement or market entry in Europe. Their services include strategic planning for market access and pricing, health economics and outcomes research, policy advisory, value communication, stakeholder engagement, advocacy development, real-world evidence generation, systematic reviews/clinical writing support. They blend online resources ("MAP Online") with bespoke consultancy to support the entire product lifecycle from pre-launch through post-launch phases. The company has expanded its European footprint by acquiring SKC Beratungsgesellschaft mbH in Germany as part of The MAP Group.